Overview of activities, risk factors
2.4 Description and strategy of the Divisions
DANONE
REGISTRATION DOCUMENT 2015
17
Waters
The Waters Division comprises the natural waters business along
with
Aquadrinks
(waters flavored and vitamin-enriched with natural
fruit juice extracts, fruit juice and vitamins).
The Division has international brands such as
evian
,
Volvic
and
Badoit
and very strong local brands:
Aqua
in Indonesia,
Mizone
in China,
Bonafont
inMexico
, Villavicencio
and
Villa del Sur
in Argentina,
Fontvella
and
Lanjarón
in Spain and
Zywiec Zdroj
in Poland.
The Division's strategy is based primarily on the development of
bottled water and
Aquadrinks
consumption, notably through the
following measures:
•
promotionof hydration-relatedhealthbenefits: Danone is establish-
ing initiatives to promote healthier hydration through partnerships
with public health authorities and scientists and by communicating
directlywith consumers in order to inspire healthier hydrationprac-
tices. In particular, the Company runs the “Hydration for Health”
scientific platform. For the past seven years, 150 scientists and
public health authority researchers from around the world have
met annually to share and promote the advances in the area of
hydration science and its positive effect on health;
•
long-term management and environmental protection of water
resources: Danone strives to preserve the unique quality and
sustainable nature of its natural waters products by strengthen-
ing the protection of its springs and respecting the water cycle.
Danone is also committed to getting all socio-economic players
involved through associations and partnerships that promote the
development of non-polluting activities and the establishment of
agricultural practices that do less harmto the environment around
the catchment areas;
•
the development of a line of light andnatural beverages, alternatives
to sodas and other sweetened beverages. The challenge is to facil-
itate the adoption of healthier hydration practices for consumers of
sweetened beverages. Many of the Company's water brands also
come in flavored versions or mixed with fruit juice,
i.e. Aquadrinks;
•
packaging innovation: in order to reduce its environmental impact,
the Division has substantially reduced the weight of its bottles over
many years and uses newpackagingmaterials such as onesmade
from plant-based or recycled materials.
Early Life Nutrition
The Early Life Nutrition Division focuses on the first 1,000 days of the
child,
i.e.
from the first day of pregnancy until age 2. The Division's
activity consists of specialized foods for babies and young children to
complement breast-feeding while always complying with the World
HealthOrganization (WHO) Code and local laws. It also offers products
and services to pregnant women and nursing mothers.
Theinfantformulasegmentaccountsformorethan80%ofthisDivision's
activity, witha special emphasis on the development of second and third
stage follow-up milks (designed for children at least six months old).
Supplementary foods for babies, also known as “weaning food”,
account for more than 10% of the activity and are marketed mainly in
European countries such as France, Italy and Poland.
The Division's development strategy is built around a singlemain area
of focus, namely developing products suitable for a child's first years,
and consists of three priorities:
•
demonstrate the relevance of this category of Early Life Nutrition
brands as an answer to the specific needs of pregnant women,
nursingmothers, babies and young children by raising awareness
amongparents, opinion leaders andhealthcare professionals about
the importance of nutrition during the first 1,000 days;
•
associate health and flavor as two indivisible qualities in baby food.
The Early Life Nutrition Division is very active in research on taste
acquisition in the youngest children and prepares products offering
awide range of flavors, in close collaborationwith sensory experts;
•
determine local nutritional needs, notably in the new regionswhere
the Division is growing by studying local dietary practices as well
as the state of nutrition in order to provide answers to local public
health challenges in accordance with the requirements of health
authorities and local associations.
The Division deploys its local brands from international brand plat-
forms, thereby enabling the global and rapid dissemination of best
practices from each country. For example:
•
the “Blue House” platform includes in particular the
Aptamil,
Nutrilon, Almiron
and
Gallia
brands;
•
the “Heritage Brands” platform includes mainly the
Bebelac,
Cow&Gate, Blédina, Malyutka
and
Dumex
brands.
Medical Nutrition
The Medical Nutrition Division focuses mainly on dietary manage-
ment of patients receiving medical treatment, babies afflicted with
certain illnesses and frail elderly people. The Division's products are
designed primarily to treat malnutrition due to disease in order to
satisfy special food needs. These products –most of which are eligible
for insurance reimbursement – are recommended or prescribed by
healthcare professionals (doctors, medical personnel in hospitals,
clinics and pharmacies).
Under the umbrella brand
Nutricia
, the Company has a large portfolio
of brands marketed in several countries, including for example:
•
Nutrison
: tube feeding for dietarymanagement of patients who are
not capable of feeding themselves normally or who suffer from
illness-related malnutrition;
•
Fortimel/Fortisip
: liquid oral nutritional supplements;
•
Neocate
: hypoallergenic products aimed at babies and children
with dairy or multiple food protein allergies;
•
Nutrini/Infatrini
: oral and feeding tube food products adapted for
the dietary treatment of babies and children who, due to illness,
are incapable of feeding themselves normally or sufficiently or
suffer from malnutrition.
Danone's strategy consists of increasing its global coverage by
establishing in new countries and developing various distribution
channels. The Company estimates that themedical nutritionmarket's
growth potential is significant, mainly as a result of (i) the aging of
the population in some countries, (ii) the increased awareness of
the role of nutrition in health, (iii) the emergence of new illnesses
and allergies, and (iv) the growing number of screening procedures
enabling early management of afflicted patients. Moreover, current
research to accompany certain illnesses and allergies could con-
tribute to this growth potential.




